The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Immunohistochemical-based diagnosis of lung adenocarcinoma subtypes reproduces the results of gene expression profiling.
A. S. Lucas
No relevant relationships to disclose
M. D. Wilkerson
No relevant relationships to disclose
P. J. Roberts
No relevant relationships to disclose
M. C. Hayward
No relevant relationships to disclose
J. E. Grilley-Olson
No relevant relationships to disclose
T. Stinchcombe
No relevant relationships to disclose
M. A. Socinski
Honoraria - Genentech; Lilly
Research Funding - Celgene; Genentech; Lilly; Pfizer; Synta
N. K. Veeramachaneni
No relevant relationships to disclose
B. E. Haithcock
No relevant relationships to disclose
W. K. Funkhouser
No relevant relationships to disclose
D. N. Hayes
No relevant relationships to disclose